AC Immune CEO Andrea Pfeifer awarded Prix BioAlps 2013

The annual award honors personalities from the life sciences industry of the Western Switzerland Region who have significantly contributed to the international reputation of the BioAlps cluster. The prize recognizes Andrea Pfeifer’s personal qualities along with the successful development of a thriving biotech company.

During her speech Andrea Pfeifer said: “I feel very much honored and personally touched to receive this recognition from the BioAlps Association, who do a great job to ensure our region remains one of the leading global centers of the life science industry. A warm thank you goes to my team at AC Immune, who tirelessly, competently and full heartedly work to realize our common dream of finding a cure for Alzheimer’s disease."

She continued “Today there are no approved therapies for Alzheimer’s disease which affects 35 million people worldwide and more than 100,000 in Switzerland, leading to an incredible burden for patients but also for their families and society. I strongly hope that we will achieve our goal of curing and preventing this disease which is one of the greatest healthcare challenges of this century. To meet this challenge, we must deploy the great brains and experiences of the world’s leading scientists, healthcare professionals and government responsibles. That is why I am dedicating the BioAlps award to all global efforts in Alzheimer’s disease research.”